Series Editor(s): Rishabha Malviya

Scope: The series offers a comprehensive exploration of the scientific landscape surrounding infectious and rare diseases. Within the epidemiological and pathogenic realm, the series delves into meticulous analyses of disease prevalence, distribution patterns, and the intricate molecular and cellular mechanisms underpinning pathogenesis. The diagnostic segment scrutinizes state-of-the-art techniques, including advanced imaging and molecular diagnostic modalities, with a focus on integrating artificial intelligence and machine learning to enhance precision and efficiency in disease diagnosis. Immunotherapy and vaccine development form another crucial aspect, featuring a thorough examination of innovative immunotherapeutic strategies tailored for infectious and rare diseases, along with breakthroughs in vaccine technologies. The series also confronts the escalating challenge of antimicrobial resistance in infectious diseases, probing into novel antimicrobial agents and stewardship programs designed to counter resistance. The scope extends to rare disease research, providing in-depth studies on the genetic and molecular foundations of rare diseases. This includes advancements in personalized medicine, featuring gene therapies and precision treatments. Global health perspectives are also a significant focus, examining the international impact of infectious diseases on public health and highlighting collaborative efforts to control their spread. Public health interventions take center stage, with discussions encompassing policies and strategies aimed at preventing and controlling infectious diseases. The series critically assesses the effectiveness of public health interventions in various socio-economic contexts. Furthermore, case studies detailing successful diagnosis and treatment approaches are presented, offering real-world applications, and ongoing or completed clinical trials are scrutinized to provide insights into the latest developments in the field.

About the Series Editor(s):
Dr. Rishabha Malviya completed B. Pharmacy from Uttar Pradesh Technical University and M. Pharmacy (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His PhD (Pharmacy) work was in the area of novel formulation development techniques. He has 14 years of research experience and has been an associate professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University for the past 11 years. His area of interest includes formulation optimization, nanoformulations, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research/review papers for national/international journals. He has 58 patents (19 granted, 38 published, 1 filed) and publications in reputed national and international journals with a total of 350 cumulative impact factor. He has also received an Outstanding Reviewer award from Elsevier. He has authored/edited more than 80 books for major publishers including the Wiley-Scrivener imprint and authored about 150 book chapters. His name has been included in the world’s top 2% scientist list for the years 2020, 2021 and 2022 by Elsevier and Stanford University. He is a reviewer/editor/editorial board member of more than 50 national and international journals.

Submission to the series:

Published and Forthcoming Titles